Wells Fargo & Company Century Therapeutics, Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 8,263 shares of IPSC stock, worth $20,657. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,263
Previous 7,203
14.72%
Holding current value
$20,657
Previous $23,000
47.83%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IPSC
# of Institutions
67Shares Held
19.7MCall Options Held
10.6KPut Options Held
300-
Vr Adviser, LLC New York, NY3.41MShares$8.51 Million1.22% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$8.02 Million1.08% of portfolio
-
Boxer Capital, LLC San Diego, CA1.75MShares$4.38 Million0.38% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$3.75 Million0.0% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA1.31MShares$3.27 Million1.32% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $147M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...